237 related articles for article (PubMed ID: 7864832)
1. Interaction of non-conjugated olefinic substrate analogues with dopamine beta-monooxygenase: catalysis and mechanism-based inhibition.
Sirimanne SR; May SW
Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):77-85. PubMed ID: 7864832
[TBL] [Abstract][Full Text] [Related]
2. Olefin oxygenation and N-dealkylation by dopamine beta-monooxygenase: catalysis and mechanism-based inhibition.
Padgette SR; Wimalasena K; Herman HH; Sirimanne SR; May SW
Biochemistry; 1985 Oct; 24(21):5826-39. PubMed ID: 4084493
[TBL] [Abstract][Full Text] [Related]
3. Mechanism-based inactivation of dopamine beta-monooxygenase in adrenal chromaffin cells.
May SW; Young FK; Powers JL; Gill-Woznichak MM
Biochem Biophys Res Commun; 1996 Nov; 228(2):278-84. PubMed ID: 8920906
[TBL] [Abstract][Full Text] [Related]
4. Mechanism-based inactivation of dopamine beta-hydroxylase by p-cresol and related alkylphenols.
Goodhart PJ; DeWolf WE; Kruse LI
Biochemistry; 1987 May; 26(9):2576-83. PubMed ID: 3607034
[TBL] [Abstract][Full Text] [Related]
5. Mechanism-based inhibition of dopamine beta-monooxygenase by aldehydes and amides.
Bossard MJ; Klinman JP
J Biol Chem; 1986 Dec; 261(35):16421-7. PubMed ID: 3782127
[TBL] [Abstract][Full Text] [Related]
6. A proton-shuttle mechanism mediated by the porphyrin in benzene hydroxylation by cytochrome p450 enzymes.
de Visser SP; Shaik S
J Am Chem Soc; 2003 Jun; 125(24):7413-24. PubMed ID: 12797816
[TBL] [Abstract][Full Text] [Related]
7. Alternate substrates of dopamine beta-hydroxylase. I. Kinetic investigations of benzyl cyanides as substrates and inhibitors.
Colombo G; Rajashekhar B; Giedroc DP; Villafranca JJ
J Biol Chem; 1984 Feb; 259(3):1593-600. PubMed ID: 6693426
[TBL] [Abstract][Full Text] [Related]
8. Use of isotope effects to characterize intermediates in mechanism-based inactivation of dopamine beta-monooxygenase by beta-chlorophenethylamine.
Bossard MJ; Klinman JP
J Biol Chem; 1990 Apr; 265(10):5640-7. PubMed ID: 2318829
[TBL] [Abstract][Full Text] [Related]
9. What factors affect the regioselectivity of oxidation by cytochrome p450? A DFT study of allylic hydroxylation and double bond epoxidation in a model reaction.
de Visser SP; Ogliaro F; Sharma PK; Shaik S
J Am Chem Soc; 2002 Oct; 124(39):11809-26. PubMed ID: 12296749
[TBL] [Abstract][Full Text] [Related]
10. An acetylenic mechanism-based inhibitor of dopamine beta-hydroxylase.
Colombo G; Villafranca JJ
J Biol Chem; 1984 Dec; 259(24):15017-20. PubMed ID: 6511785
[TBL] [Abstract][Full Text] [Related]
11. Mechanism-based inhibitors of dopamine beta-hydroxylase: inhibition by 2-bromo-3-(p-hydroxyphenyl)-1-propene.
Colombo G; Rajashekhar B; Giedroc DP; Villafranca JJ
Biochemistry; 1984 Jul; 23(16):3590-8. PubMed ID: 6477886
[TBL] [Abstract][Full Text] [Related]
12. Mode of substrate interaction and energetics of carbon-oxygen bond formation of the dopamine beta-monooxygenase reaction.
Wimalasena K; Alliston KR
Biochemistry; 1999 Nov; 38(45):14916-26. PubMed ID: 10555974
[TBL] [Abstract][Full Text] [Related]
13. Mechanism-based inhibitors of dopamine beta-hydroxylase.
Fitzpatrick PF; Villafranca JJ
Arch Biochem Biophys; 1987 Sep; 257(2):231-50. PubMed ID: 3662525
[TBL] [Abstract][Full Text] [Related]
14. Hydroxylation of specifically deuterated limonene enantiomers by cytochrome p450 limonene-6-hydroxylase reveals the mechanism of multiple product formation.
Wüst M; Croteau RB
Biochemistry; 2002 Feb; 41(6):1820-7. PubMed ID: 11827526
[TBL] [Abstract][Full Text] [Related]
15. Ascorbate depletion as a consequence of product recycling during dopamine beta-monooxygenase catalyzed selenoxidation.
May SW; Herman HH; Roberts SF; Ciccarello MC
Biochemistry; 1987 Mar; 26(6):1626-33. PubMed ID: 3036204
[TBL] [Abstract][Full Text] [Related]
16. Catalytic mechanism of dopamine beta-monooxygenase mediated by Cu(III)-oxo.
Yoshizawa K; Kihara N; Kamachi T; Shiota Y
Inorg Chem; 2006 Apr; 45(7):3034-41. PubMed ID: 16562959
[TBL] [Abstract][Full Text] [Related]
17. Effects of dopamine beta-monooxygenase substrate analogs on ascorbate levels and norepinephrine synthesis in adrenal chromaffin granule ghosts.
Wimalasena K; Herman HH; May SW
J Biol Chem; 1989 Jan; 264(1):124-30. PubMed ID: 2909510
[TBL] [Abstract][Full Text] [Related]
18. Interaction of dopamine-beta-monooxygenase with lipids: 1. Lipids as modulators of the catalytic activity of the enzyme.
Boyadzhyan AS; Karagezyan KG
Biomed Sci; 1990 Apr; 1(4):379-83. PubMed ID: 2133056
[TBL] [Abstract][Full Text] [Related]
19. Interaction of dopamine beta-mono-oxygenase with substituted imidazoles and pyrazoles. Catalysis and inhibition.
Sirimanne SR; Herman HH; May SW
Biochem J; 1987 Feb; 242(1):227-33. PubMed ID: 3593236
[TBL] [Abstract][Full Text] [Related]
20. The reactivation of apodopamine beta-monooxygenase by vanadyl ions.
Markossian KA; Paitian NA; Nalbandyan RM
FEBS Lett; 1988 Oct; 238(2):401-4. PubMed ID: 2844606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
